Cibc World Market Inc. Makes New Investment in Acadia Healthcare Company, Inc. $ACHC

Cibc World Market Inc. acquired a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the second quarter, Holdings Channel reports. The institutional investor acquired 118,780 shares of the company’s stock, valued at approximately $3,508,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of ACHC. EverSource Wealth Advisors LLC grew its stake in Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares in the last quarter. Allworth Financial LP acquired a new stake in Acadia Healthcare in the 2nd quarter valued at about $45,000. Wells Fargo & Company MN raised its position in Acadia Healthcare by 208.9% in the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after purchasing an additional 1,510 shares in the last quarter. Global Retirement Partners LLC purchased a new position in shares of Acadia Healthcare in the 2nd quarter valued at about $68,000. Finally, Quantbot Technologies LP acquired a new position in shares of Acadia Healthcare during the second quarter worth about $88,000.

Acadia Healthcare Trading Up 2.4%

ACHC opened at $30.58 on Thursday. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.57 and a current ratio of 1.57. Acadia Healthcare Company, Inc. has a one year low of $11.43 and a one year high of $35.83. The company has a market cap of $2.85 billion, a P/E ratio of -2.46, a PEG ratio of 9.62 and a beta of 0.64. The business’s 50-day simple moving average is $30.28 and its 200-day simple moving average is $25.93.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.03. The firm had revenue of $865.84 million during the quarter, compared to analysts’ expectations of $844.19 million. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The firm’s revenue was down .4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.83 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, equities research analysts expect that Acadia Healthcare Company, Inc. will post 1.55 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms recently weighed in on ACHC. KeyCorp upped their target price on shares of Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 14th. Royal Bank Of Canada lifted their price target on shares of Acadia Healthcare from $28.00 to $31.00 and gave the stock an “outperform” rating in a research note on Monday, May 4th. Raymond James Financial upgraded shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price target for the company in a report on Monday, May 4th. TD Cowen raised their price objective on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Finally, UBS Group lifted their price objective on shares of Acadia Healthcare from $31.00 to $39.00 and gave the stock a “buy” rating in a research report on Thursday, July 9th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, Acadia Healthcare has an average rating of “Hold” and a consensus price target of $29.85.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.